Surgery For Cure Followed By Chemotherapy In Small Cell Carcinoma Of The Lung: For The Isc-Lung Cancer Study Group

References

• Henderson D E. Future Directions for the American Joint Commitee on Cancer. Cancer 1992; 69: 1639–44
   PubMedGoogle Scholar
• Miller A B, Fox W, Tall R. Five‐year follow‐up of the Medical Research Council comparative trial of surgery and radiotherapy for the primary treatment of small celled or oat‐celled carcinoma of the bronchus. Lancet 1969; 2: 501–5
   PubMed Web of Science ®Google Scholar
• Mountain C L. Prognostic implications of the international staging system for lung cancer. Semin Oncol 1988; 15: 236–46
   PubMedGoogle Scholar
• Selawry O S. Monochemotherapy of bronchogenic carcinoma with special reference to cell type. Cancer Chemother Rep 1973; 4: 177–88
   Google Scholar
• Selawry O S, Hansen H H. Lung cancer. Cancer medicine, J F Holland, E Frei, III. Lea & Febiger, Philadelphia 1973; 1473–518
   Google Scholar
• Aisner J, Alberto P, Bitran J, et al. Role of chemotherapy in small cell lung cancer: A consensus report of the IASLC‐workshop. Cancer Treatm Rep 1983; 67: 37–43
   PubMedGoogle Scholar
• Leonard R C F. Small cell lung cancer. Br J Cancer 1989; 59: 487–90
   PubMedGoogle Scholar
• Diggs C H, Engeler J E, Jr, Prendergast E J, Kramer K. Small cell carcinoma of the lung. Cancer 1992; 69: 2075–83
   PubMedGoogle Scholar
• Seifter E J, Ibde D C. Therapy of small cell lung cancer: a perspective on two decades of clinical research. Semin Oncol 1988; 15: 278–99
   PubMed Web of Science ®Google Scholar
• Ginsberg R J, Karrer K. Surgery in small cell lung cancer: a consensus report. Lung Cancer, Elsevier. 1989; 5: 139
   Google Scholar
• Turrisi A T, Glover D J. Thoracic radiotherapy variables: influence on local control in small cell lung cancer limited disease. Int J radiat Oncol Biol Phys 1990; 19: 1473–9
   PubMed Web of Science ®Google Scholar
• Denk W, Karrer K. Combined surgery and chemotherapy in the treatment of malignant tumors. Cancer 1961; 14: 1197–204
   PubMedGoogle Scholar
• Karrer K. Adjuvant chemotherapy of postsurgical minimal residual cronchial carcinomas. Recent Results. Cancer Res 1979; 68: 246–59, Bonadonna, G, Mathé G, Salmon SE eds.
   Google Scholar
• Massen W, Greschuchna D. Small cell carcinoma of the lung—to operate or not? Surgical experience and results. Thorac Cardiovasc Surg 1986; 34: 71–6
   PubMedGoogle Scholar
• Karrer K, Shields T W, Denck H. The importance of surgical and multimodality treatment for small cell bronchial carcinoma. J Thorac Cardiovasc Surg 1989; 97: 168–76
   PubMed Web of Science ®Google Scholar
• Karrer K, Humphreys S R, Goldin A. An experimental model for studying factors which influence metastasis of malignant tumors. Int J Cancer 1967; 2: 213–23
   PubMed Web of Science ®Google Scholar
• Skipper H E, Schabel F M, Jr. Quantitative and cytogenic studies in experimental tumor models. Cancer medicine, J F Holland, E Frei, III. Lea & Febiger, Philadelphia 1973, 648 Table XII‐3–7
   Google Scholar
• Osterlind K. Surgery in small cell lung cancer: some quantitative aspects. Lung Cancer. Elsevier 1990; 6: 84–5
   Google Scholar
• Verter J. How much data should we collect in a randomized trial? Stat Med 1990; 9: 103–13
   Google Scholar
• Kreismann H, Wolkove N, Quoix E. Small cell lung cancer presenting as a solitary pulmonary nodule. Chest 1992; 101: 225
   PubMedGoogle Scholar
• Ulsperger E, Shields T W, Karrer K. The role of surgery in small cell lung cancer. Lung Cancer. Elsevier 1990; 6: 73–83
   Google Scholar
• UICC. TNM‐classification of malignant tumors4th fully revised edition, P Hermanek, O Scheibe, B Spiessl, G Wagner. Springer‐Verlag, Berlin/Heidelberg 1987
   Google Scholar
• UICC. TNM‐Atlas. Illustrated guide to the TNM/pTNM classification of malignant tumors.Third Edition, B Spiessl, P H Beahrs, O Hermanek, R V P Hutter, O Scheibe, L H Sobin, G Wagner. Springer‐Verlag, Berling/Heidelberg 1989
   Google Scholar
• Denk W, Karrer K. Modellversuch einer Rezidivprophylaxe des Karzinoms. Wien Klin Wochenschr 1955; 67: 986
   Google Scholar
• Karrer K, Pridun N, Denck H. Chemotherapy as an adjuvant to surgery in lung cancer. Cancer Chemother Pharmacol 1978; 1: 145–59
   PubMed Web of Science ®Google Scholar
• Karrer K, Denck H, Pridun N. Combination of early surgery for cure and polychemotherapy in small cell bronchial carcinoma. Proceedings of the 13th International Congress of Chemotherapy, Vienna., K H Spitzy, K Karrer. Publ. Egermann, Vienna 1983; 11: 228/52–60
   Google Scholar
• Shields T, Matthews M J. Adjuvant therapy of small cell bronchial carcinoma. Cancer Treat Rev 1984; 11: 331–3
   PubMedGoogle Scholar
• Lad T, Thomas P, Piantadosi S. Surgical resection of small cell lung cancer—a prospective randomized evaluation. Lung Cancer. Elsevier 1991; 7(No. 604)162, Suppl
   Google Scholar
• Kreyberg L. Histological typing of lung tumors. WHO, Geneva 1967
   Google Scholar
• Matthews M J, Rozencweig M, Staguet M J, Minna J D, Muggia F M. Long‐term survivors with small cell carcinoma of the lung. Eur Cancer 1980; 16: 527–31
   PubMedGoogle Scholar
• Hirsch F R, Matthews M J, Aisner S, et al. Histophathologic classification of small cell lung cancer. Changing concepts and terminology. Cancer 1988; 62: 973–7
   PubMed Web of Science ®Google Scholar
• Naruke T, Suemasu K, Ishikawa S. Mediastinal lymph node direction and its significance in surgery of lung cancer. Lung Cancer. Elsevier 1986; 96
   Google Scholar
• Kaplan E L, Meier P. Neoparametric estimation from incomplete observations J Am Stat Assoc 1958; 53: 457–81
   Google Scholar
• Breslow N. A generalized Kruskal‐Wallis test for comparing k‐analysis subject to inequal patterns of censorship. Biometrika. 1970; 57: 579–94
   Web of Science ®Google Scholar
• Shepherd F A, Ginsberg R J, Feld R, Evans W K, Johansen E. Surgical treatment for limited small cell lung cancer, the University of Toronto Lung Oncology Group experience. J. Thorac Cardiovasc Surg 1991; 101: 385–93
   PubMedGoogle Scholar
• Salzer G M, Praeuer H, Mueller L, Huber H, Frommhold H. Langzeitergebnisse nach multimodaler Therapie des kleinzelligen Bronchialkarzinoms mit Einschluss der Chirurgie. Langenbecks Arch Chir Suppl Kongressbd 1991; 544–8
   PubMedGoogle Scholar
• Macchiarini P, Hardin M, Basolo F, Bruno J, Chella A, Angeletti C A. Surgery plus adjuvant chemotherapy for TI‐3N0M0 small cell lung cancer. Rationale for current approach. Am J Clin Oncol 1991; 14: 218–24
   PubMedGoogle Scholar
• Zejian L, Hua R, Zhiyong Z, et al. Treatment of small cell lung cancer. Lung Cancer. Elsevier 1991; 7(No. 290)80, Suppl.
   Google Scholar
• Zhou H N, Liu G S, Zeng G C, Chen Y F. Diagnosis and treatment of small cell lung cancer to discuss and consider. Lung Cancer. Elsevier 1991; 7(No. 253)71, Suppl.
   Google Scholar
• Debevec M, Orel J. Treatment of small cell lung cancer by surgery, chemotherapy and irradiation. Lung Cancer. Elsevier 1991; 7: 399–44
   Google Scholar
• Abrams J, Doyle L A, Aisner J. Staging, prognostic factors and special considerations in small cell lung cancer. Semin Oncol 1988; 15: 261–77
   PubMedGoogle Scholar
• Favaretto A, Paccagnella A, Pappagallo G, et al. Survial and prognostic factors in small cell lung cancer. Results on 273 patients treated with alternating CT (and surgery for operable pts.). Eur J Cancer 1991; 27(Suppl. 2)182, No. 1108
   PubMedGoogle Scholar
• Holoye P Y, McMurtrey M J, Mountain C F, et al. The role of adjuvant surgery in the combined modality therapy of small cell bronchogenic carcinoma after a chemotherapy‐induced partial remission. J Clin Oncol 1990; 8: 416–22
   PubMedGoogle Scholar
• Zatopek N K, Holye P Y, Ellerbroek N A, et al. Resectability of small cell lung cancer following induction chemotherapy in patients with limited disease (stage II‐IIIb). Am J Clin Oncol 1991; 14: 427–32
   PubMedGoogle Scholar
• Gridelli C, Maiorino A, Curcio C, et al. Carboplatin plus epirubicin plus VP‐16, concurrent radiotherapy and adjuvant surgery for limited SCLC. Eur J Cancer 1991; 27(Suppl. 2)186, No. 1130
   Google Scholar
• Taniguchi K, Tsubota N, Kawaguchi H, Nakamoto K, Maeda M. Surgical usage of dose intensive chemotherapy with G‐CSF; KRN 8601 for advanced lung cancer. Lung Cancer. Elsevier 1991; 7(No. 593)159, (Suppl.)
   Google Scholar
• Rocmans P A, Capello M, de Francquen P, Jacobovitz D. Feasibility of surgery after chemotherapy. Lung Cancer. Elsevier 1991; 7(No. 302)83, Suppl.
   Google Scholar
• Yamamoto M, Masaki Y, Mishimura H, Yoneda S, Sakura M. Thoractomy after chemoradiotherapy—a study on 20 lung cancer patients. Lung Cancer. Elsevier 1991; 7(No 595)160, (suppl)
   Google Scholar
• Kemmer H P, Schmidt B V, Zwehl D, Reichle G, Macha H N, Achatzy R. Combined modality treatment in patients with small cell lung cancer. Eur J Cancer 1991; 27(Suppl 2)218, No 1331
   Google Scholar
• Lewinski T, Zulawski M, Turski C, et al. Surgery after chemotherapy with continuation of chemotherapy in limited, including N2 small cell lung cancer: A prospective study. Lung Cancer. Elsevier 1991; 7(Suppl.)72, No. 259
   Google Scholar
• Kaiser D, Fritzsche A, Matthiessen W. Operationsindikation beim kleinzelligen Bronchuskarzinom. Dtsch Med Wschr 1992; 117: 103–6
   PubMedGoogle Scholar
• Hansen H H. Management of small cell cancer of the lung. Lancet 1992; 339: 846
   PubMedGoogle Scholar
• Lequaglie C, Patriarca C, Cataldo I, Muscolino G, Preda F, Ravasi G. Prognosis of resected well‐differentiated neuroendocrine carcinoma of the lung. Chest 1991; 100: 1053–6
   PubMedGoogle Scholar
• Toomes H, Semik M. Combined therapy of small cell bronchial carcinoma. Lung Cancer. Elsevier 1991; 7(No. 598)160, Suppl.
   Google Scholar
• Hara N, Ohta Tomoharu K, Akira M, Asoh H. Influence of surgical resection before and after chemotherapy on survival in small cell lung cancer. J Surg Oncol 1991; 47: 53
   PubMedGoogle Scholar
• Karrer K, Shields T. The importance of complete resection in the multimodality treatment of SCLC. Lung Cancer. Elsevier 1991; 71(No. 254), (Suppl.)
   Google Scholar
• Matrorilli M, Bragaglia R B, Cipolla D'Abruzzo, et al. Acturial 5–year survival after resection of N2 lung cancer. Lung Cancer. Elsevier 1991; 7(No. 281)78, Suppl.
   Google Scholar
• Valente M, Musumeci R, Tavecchio L, et al. Resectable N2 disease according to the predicted location of enlarged mediastinal nodes. Lung Cancer. Elsevier 1991; 7(No. 311)85, Suppl.
   Google Scholar
• Gotti G, Paladini P, Maccherini M, et al. The survival in different N2 site infiltration in patients operated on for lung cancer. Lung Cancer. Elsevier 1991; 7(No. 316)86, Suppl.
   Google Scholar
• Theuer W, Karrer K. Multimodality treatment including surgery for patients with small cell lung cancer (SCLC). Eur J Cancer 1991; 27(Suppl 2)182, No. 1107
   PubMedGoogle Scholar
• Greenberg E R, Chute C G, Stukel T, et al. Social and economic factors in the choice of lung cancer treatment. N Engl J Med 1988; 318: 612–7
   PubMed Web of Science ®Google Scholar
• Theuer W, Holzner J H, Karrer K, for the ISC‐Lung Cancer Study Group. The importance of staging and pathohistological subtyping in small celled lung cancer (SCLC). J Cancer Res Clin Oncol 1991; 188(No. 40), (Suppl.)
   Google Scholar
• Ihde D C, Pass H J, Glatstein E J. Small cell lung cancer. Cancer principles and practice of oncology, V T Devitam, Jr, S Hellman, S A Rosenberg. Lippincott JB Company, Philadelphia 1993; 723–58
   Google Scholar
• Jett J R. Role of interferon in SCLC. Lung Cancer 1989; 5: 281–95
   Google Scholar
• Mattson K, Niiranen A, Pyrhnen S, et al. Natural interferon alfa as a maintenance therapy for small cell lung cancer. Eur J Cancer 1992; 28A: 1387–91
   PubMed Web of Science ®Google Scholar
• Bunn P A, Cullen M, Fukuoka M, et al. Chemotherapy in small cell lung cancer. Lung Cancer 1989; 5: 127–34
   Google Scholar
• Bunn P A, Jr. Dedication. Semin Oncol 1988; 15: 197
   PubMedGoogle Scholar